Advances in multiparametric magnetic resonance imaging (mpMRI) hold promise for the improved detection and characterization of prostate cancer. MpMRI combines diffusion-weighted imaging, dynamic contrast-enhanced sequences, or spectroscopy with conventional T2-weighted sequences. With a combination of anatomic and functional imaging sequences to identify suspicious regions in the prostate, pre-biopsy mpMRI has the potential to improve prostate cancer detection and risk stratification through MRI-targeted biopsy. In this chapter we review the role of mpMRI in prostate cancer detection, the outcomes of MRI-targeted biopsy, and the critical concepts currently under evaluation in validation of an MRI-based prostate cancer risk stratification strategy.
|Original language||English (US)|
|Title of host publication||The Prostate Cancer Dilemma|
|Subtitle of host publication||Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy|
|Publisher||Springer International Publishing|
|Number of pages||20|
|State||Published - Jan 1 2016|
ASJC Scopus subject areas